{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:20:14Z","timestamp":1762161614725},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Atrial fibrillation (AF) is part of a\u00a0vicious cycle that includes multiple cardiovascular risk factors and comorbidity which can promote atrial remodelling and AF progression. Most AF-related risk factors\u2014hypertension, diabetes, sleep apnoea, obesity and sedentary lifestyle\u2014are in essence modifiable which may prevent AF development. Treatment of associated cardiovascular conditions may prevent both symptoms and future cardiovascular events. For advanced forms of symptomatic AF refractory to lifestyle management and optimal medication, invasive ablation therapies have become a\u00a0cornerstone. Although electrical trigger isolation from the pulmonary veins is reasonably effective and safe, more potent energy sources including high output-short duration radiofrequency, ultra-low cryo-energy, and electroporation, as well as more sophisticated arrays, balloons, and lattice-tipped catheter tools, are on their way to eliminate existing pitfalls and simplify the procedure. Electroanatomical navigation and mapping systems are becoming available to provide real-time information on ablation lesion quality and the critical pathways of AF in the individual patient to guide more extensive ablation strategies that may enhance long-term outcome for freedom of advanced AF. Surgical techniques, either stand-alone or concomitant to structural cardiac repair, hybrid, or convergent, with novel less invasive access options are developing and can be helpful in situations unsuitable for catheter ablation.<\/jats:p>","DOI":"10.1007\/s12471-020-01447-5","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T14:04:55Z","timestamp":1597154695000},"page":"13-18","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic options for patients with advanced atrial fibrillation: from lifestyle and medication to catheter and surgical ablation"],"prefix":"10.1007","volume":"28","author":[{"given":"L.","family":"Boersma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rienstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"1447_CR1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jacc.2015.06.1314","volume":"66","author":"RA Vermond","year":"2015","unstructured":"Vermond\u00a0RA, Geelhoed\u00a0B, Verweij\u00a0N, et al. Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands. J\u00a0Am Coll Cardiol. 2015;66:1000\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1447_CR2","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof\u00a0P, Benussi\u00a0S, Kotecha\u00a0D, et\u00a0al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart\u00a0J. 2016;37:2893\u2013962.","journal-title":"Eur Heart J"},{"key":"1447_CR3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/HJH.0b013e32834f03bf","volume":"30","author":"AJ Manolis","year":"2012","unstructured":"Manolis\u00a0AJ, Rosei\u00a0EA, Coca\u00a0A, et\u00a0al. Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group \u2018Hypertension Arrhythmias and Thrombosis\u2019 of the European Society of Hypertension. J\u00a0Hypertens. 2012;30:239\u201352.","journal-title":"J Hypertens"},{"key":"1447_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","volume":"386","author":"RB Schnabel","year":"2015","unstructured":"Schnabel\u00a0RB, Yin\u00a0X, Gona\u00a0P, et\u00a0al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a\u00a0cohort study. Lancet. 2015;386:154\u201362.","journal-title":"Lancet"},{"key":"1447_CR5","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","volume":"64","author":"RK Pathak","year":"2014","unstructured":"Pathak\u00a0RK, Middeldorp\u00a0ME, Lau\u00a0DH, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J\u00a0Am Coll Cardiol. 2014;64:2222\u201331.","journal-title":"J Am Coll Cardiol"},{"key":"1447_CR6","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","volume":"39","author":"M Rienstra","year":"2018","unstructured":"Rienstra\u00a0M, Hobbelt\u00a0AH, Alings\u00a0M, et\u00a0al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. Eur Heart\u00a0J. 2018;39:2987\u201396.","journal-title":"Eur Heart J"},{"key":"1447_CR7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/jce.13458","volume":"29","author":"Z Asad","year":"2018","unstructured":"Asad\u00a0Z, Abbas\u00a0M, Javed\u00a0I, Korantzopoulos\u00a0P, Stavrakis\u00a0S. Obesity is associated with incident atrial fibrillation independent of gender: A meta-analysis. J\u00a0Cardiovasc Electrophysiol. 2018;29:725\u201332.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1447_CR8","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","volume":"65","author":"RK Pathak","year":"2015","unstructured":"Pathak\u00a0RK, Middeldorp\u00a0ME, Meredith\u00a0M, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J\u00a0Am Coll Cardiol. 2015;65:2159\u201369.","journal-title":"J Am Coll Cardiol"},{"key":"1447_CR9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","volume":"66","author":"RK Pathak","year":"2015","unstructured":"Pathak\u00a0RK, Elliott\u00a0A, Middeldorp\u00a0ME, et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J\u00a0Am Coll Cardiol. 2015;66:985\u201396.","journal-title":"J Am Coll Cardiol"},{"key":"1447_CR10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/europace\/euw169","volume":"19","author":"M Proietti","year":"2017","unstructured":"Proietti\u00a0M, Boriani\u00a0G, Laroche\u00a0C, et al. Self-reported physical activity and major adverse events in patients with atrial fibrillation: a\u00a0report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. Europace. 2017;19:535\u201343.","journal-title":"Europace"},{"key":"1447_CR11","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1249\/mss.0b013e3180616b27","volume":"39","author":"WL Haskell","year":"2007","unstructured":"Haskell\u00a0WL, Lee\u00a0IM, Pate\u00a0RR, et\u00a0al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39:1423\u201334.","journal-title":"Med Sci Sports Exerc"},{"key":"1447_CR12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/europace\/euv216","volume":"18","author":"N Calvo","year":"2016","unstructured":"Calvo\u00a0N, Ramos\u00a0P, Montserrat\u00a0S, et al. Emerging risk factors and the dose-response relationship between physical activity and lone atrial fibrillation: a\u00a0prospective case-control study. Europace. 2016;18:57\u201363.","journal-title":"Europace"},{"key":"1447_CR13","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/ejhf.1283","volume":"20","author":"G van Woerden","year":"2018","unstructured":"van Woerden\u00a0G, Gorter\u00a0TM, Westenbrink\u00a0BD, Willems\u00a0TP, van Veldhuisen\u00a0DJ, Rienstra\u00a0M. Epicardial fat in heart failure patients with mid-range and preserved ejection fraction. Eur J Heart Fail. 2018;20:1559\u201366.","journal-title":"Eur J Heart Fail"},{"key":"1447_CR14","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","volume":"59","author":"K Swedberg","year":"2012","unstructured":"Swedberg\u00a0K, Zannad\u00a0F, McMurray\u00a0JJ, et al. Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. J\u00a0Am Coll Cardiol. 2012;59:1598\u2013603.","journal-title":"J Am Coll Cardiol"},{"key":"1447_CR15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2016.12.029","volume":"231","author":"J Neefs","year":"2017","unstructured":"Neefs\u00a0J, van den Berg\u00a0NW, Limpens\u00a0J, et al. Aldosterone pathway blockade to prevent atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2017;231:155\u201361.","journal-title":"Int J Cardiol"},{"key":"1447_CR16","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/kws342","volume":"177","author":"PE Peppard","year":"2013","unstructured":"Peppard\u00a0PE, Young\u00a0T, Barnet\u00a0JH, Palta\u00a0M, Hagen\u00a0EW, Hla\u00a0KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006\u201314.","journal-title":"Am J Epidemiol"},{"key":"1447_CR17","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/eurheartj\/ehn214","volume":"29","author":"IH Stevenson","year":"2008","unstructured":"Stevenson\u00a0IH, Teichtahl\u00a0H, Cunnington\u00a0D, Ciavarella\u00a0S, Gordon\u00a0I, Kalman\u00a0JM. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart\u00a0J. 2008;29:1662\u20139.","journal-title":"Eur Heart J"},{"key":"1447_CR18","doi-asserted-by":"publisher","DOI":"10.4172\/2167-0277.1000282","author":"I Youssef","year":"2018","unstructured":"Youssef\u00a0I, Kamran\u00a0H, Yacoub\u00a0M, et al. Obstructive sleep apnea as a\u00a0risk factor for atrial fibrillation: a meta-analysis. J\u00a0Sleep Disord Ther. 2018; https:\/\/doi.org\/10.4172\/2167-0277.1000282.","journal-title":"J Sleep Disord Ther"},{"key":"1447_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.sleep.2018.02.013","volume":"46","author":"F Deng","year":"2018","unstructured":"Deng\u00a0F, Raza\u00a0A, Guo\u00a0J. Treating obstructive sleep apnea with continuous positive airway pressure reduces risk of recurrent atrial fibrillation after catheter ablation: a\u00a0meta-analysis. Sleep Med. 2018;46:5\u201311.","journal-title":"Sleep Med"},{"key":"1447_CR20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","volume":"339","author":"M Haissaguerre","year":"1998","unstructured":"Haissaguerre\u00a0M, Jais\u00a0P, Shah\u00a0DC, et\u00a0al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N\u00a0Engl J Med. 1998;339:659\u201366.","journal-title":"N Engl J Med"},{"key":"1447_CR21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/europace\/eux274","volume":"20","author":"H Calkins","year":"2018","unstructured":"Calkins\u00a0H, Hindricks\u00a0G, Cappato\u00a0R, et\u00a0al. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20:e1\u2013e160.","journal-title":"Europace"},{"key":"1447_CR22","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.hrthm.2008.08.037","volume":"5","author":"LV Boersma","year":"2008","unstructured":"Boersma\u00a0LV, Wijffels\u00a0MC, Oral\u00a0H, Wever\u00a0EF, Morady\u00a0F. Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a\u00a0multielectrode ablation catheter. Heart Rhythm. 2008;5:1635\u201342.","journal-title":"Heart Rhythm"},{"key":"1447_CR23","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/eurheartj\/ehm227","volume":"28","author":"Y Van Belle","year":"2007","unstructured":"Van Belle\u00a0Y, Janse\u00a0P, Rivero-Ayerza\u00a0MJ, et al. Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome. Eur Heart\u00a0J. 2007;28:2231\u20137.","journal-title":"Eur Heart J"},{"key":"1447_CR24","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/europace\/eus188","volume":"14","author":"C Scharf","year":"2012","unstructured":"Scharf\u00a0C, Ng\u00a0GA, Wieczorek\u00a0M, et al. European survey on efficacy and safety of duty-cycled radiofrequency ablation for atrial fibrillation. Europace. 2012;14:1700\u20137.","journal-title":"Europace"},{"key":"1447_CR25","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","volume":"374","author":"KH Kuck","year":"2016","unstructured":"Kuck\u00a0KH, Brugada\u00a0J, Furnkranz\u00a0A, et\u00a0al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N\u00a0Engl J Med. 2016;374:2235\u201345.","journal-title":"N Engl J Med"},{"key":"1447_CR26","first-page":"e003337","volume":"9","author":"KH Kuck","year":"2016","unstructured":"Kuck\u00a0KH, Hoffmann\u00a0BA, Ernst\u00a0S, et al. Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the gap-atrial fibrillation-german atrial fibrillation competence network 1 trial. Circ Arrhythm Electrophysiol. 2016;9:e3337.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1447_CR27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jacep.2018.11.020","volume":"5","author":"J De Pooter","year":"2019","unstructured":"De Pooter\u00a0J, Strisciuglio\u00a0T, El Haddad\u00a0M, et\u00a0al. Pulmonary vein reconnection no longer occurs in the majority of patients after a\u00a0single pulmonary vein isolation procedure. JACC Clin Electrophysiol. 2019;5:295\u2013305.","journal-title":"JACC Clin Electrophysiol"},{"key":"1447_CR28","doi-asserted-by":"crossref","first-page":"e007661","DOI":"10.1161\/CIRCEP.119.007661","volume":"12","author":"A Shapira-Daniels","year":"2019","unstructured":"Shapira-Daniels\u00a0A, Barkagan\u00a0M, Yavin\u00a0H, et al. Novel irrigated temperature-controlled lattice ablation catheter for ventricular ablation: a preclinical multimodality biophysical characterization. Circ Arrhythm Electrophysiol. 2019;12:e7661.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1447_CR29","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","volume":"372","author":"A Verma","year":"2015","unstructured":"Verma\u00a0A, Jiang\u00a0CY, Betts\u00a0TR, et\u00a0al. Approaches to catheter ablation for persistent atrial fibrillation. New Engl J Med. 2015;372:1812\u201322.","journal-title":"New Engl J Med"},{"key":"1447_CR30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.2014.3","volume":"311","author":"NF Marrouche","year":"2014","unstructured":"Marrouche\u00a0NF, Wilber\u00a0D, Hindricks\u00a0G, et\u00a0al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311:498\u2013506.","journal-title":"JAMA"},{"key":"1447_CR31","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/europace\/euw168","volume":"19","author":"S Knecht","year":"2017","unstructured":"Knecht\u00a0S, Sohal\u00a0M, Deisenhofer\u00a0I, et al. Multicentre evaluation of non-invasive biatrial mapping for persistent atrial fibrillation ablation: the AFACART study. Europace. 2017;19:1302\u20139.","journal-title":"Europace"},{"key":"1447_CR32","doi-asserted-by":"crossref","first-page":"e007233","DOI":"10.1161\/CIRCEP.119.007233","volume":"12","author":"S Willems","year":"2019","unstructured":"Willems\u00a0S, Verma\u00a0A, Betts\u00a0TR, et\u00a0al. Targeting nonpulmonary vein sources in persistent atrial fibrillation identified by noncontact charge density mapping. Circ Arrhythm Electrophysiol. 2019;12:e7233.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1447_CR33","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.hrthm.2019.06.020","volume":"16","author":"A Romanov","year":"2019","unstructured":"Romanov\u00a0A, Dichterman\u00a0E, Schwartz\u00a0Y, et al. High-resolution, real-time, and nonfluoroscopic 3\u2011dimensional cardiac imaging and catheter navigation in humans using a\u00a0novel dielectric-based system. Heart Rhythm. 2019;16:1883\u20139.","journal-title":"Heart Rhythm"},{"key":"1447_CR34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/eurheartj\/ehw260","volume":"38","author":"P Kirchhof","year":"2017","unstructured":"Kirchhof\u00a0P, Calkins\u00a0H. Catheter ablation in patients with persistent atrial fibrillation. Eur Heart\u00a0J. 2017;38:20\u20136.","journal-title":"Eur Heart J"},{"key":"1447_CR35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0022-5223(19)36684-X","volume":"101","author":"JL Cox","year":"1991","unstructured":"Cox\u00a0JL, Schuessler\u00a0RB, D\u2019Agostino\u00a0HJJ, et\u00a0al. The surgical treatment of atrial fibrillation, III: development of a\u00a0definitive surgical procedure. J\u00a0Thorac Cardiovasc Surg. 1991;101:569\u201383.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1447_CR36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCEP.111.963819","volume":"5","author":"T Weimar","year":"2012","unstructured":"Weimar\u00a0T, Schena\u00a0S, Bailey\u00a0MS, et al. The cox-maze procedure for lone atrial fibrillation: a\u00a0single-center experience over 2 decades. Circ Arrhythm Electrophysiol. 2012;5:8\u201314.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1447_CR37","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jtcvs.2015.07.102","volume":"150","author":"MC Henn","year":"2015","unstructured":"Henn\u00a0MC, Lancaster\u00a0TS, Miller\u00a0JR, et\u00a0al. Late outcomes after the Cox maze IV procedure for atrial fibrillation. J\u00a0Thorac Cardiovasc Surg. 2015;150:1168\u20131178.e2.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1447_CR38","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1056\/NEJMoa1500528","volume":"372","author":"AM Gillinov","year":"2015","unstructured":"Gillinov\u00a0AM, Gelijns\u00a0AC, Parides\u00a0MK, et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. New Engl J Med. 2015;372:1399\u2013409.","journal-title":"New Engl J Med"},{"key":"1447_CR39","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jtcvs.2005.03.041","volume":"130","author":"RK Wolf","year":"2005","unstructured":"Wolf\u00a0RK, Schneeberger\u00a0EW, Osterday\u00a0R, et al. Video-assisted bilateral pulmonary vein isolation and left atrail appendage exclusion for atrial fibrillation. J\u00a0Thorac Cardiovasc Surg. 2005;130:797\u2013802.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1447_CR40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejcts.2010.01.058","volume":"38","author":"A Yilmaz","year":"2010","unstructured":"Yilmaz\u00a0A, Geuzebroek\u00a0GSC, Van Putte\u00a0BP, et\u00a0al. Completely thoracoscopic pulmonary vein isolation with ganglionated plexus ablation and left atrial appendage amputation for the treatment of atrial fibrillation. Eur J Cardiothorac Surg. 2010;38:356\u201360.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1447_CR41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCULATIONAHA.111.074047","volume":"125","author":"LV Boersma","year":"2012","unstructured":"Boersma\u00a0LV, Castella\u00a0M, van Boven\u00a0W, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a\u00a02-center randomized clinical trial. Circulation. 2012;125:23\u201330.","journal-title":"Circulation"},{"key":"1447_CR42","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/europace\/eux385","volume":"20","author":"LM Vos","year":"2018","unstructured":"Vos\u00a0LM, Kotecha\u00a0D, Geuzebroek\u00a0GSC, et\u00a0al. Totally thoracoscopic ablation for atrial fibrillation: a\u00a0systematic safety analysis. Europace. 2018;20:1790\u20137.","journal-title":"Europace"},{"key":"1447_CR43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2018.11.127","volume":"278","author":"WR Berger","year":"2019","unstructured":"Berger\u00a0WR, Meulendijks\u00a0ER, Limpens\u00a0J, et al. Persistent atrial fibrillation: A systematic review and meta-analysis of invasive strategies. Int J Cardiol. 2019;278:137\u201343.","journal-title":"Int J Cardiol"},{"key":"1447_CR44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.hrthm.2009.12.008","volume":"7","author":"J Kron","year":"2010","unstructured":"Kron\u00a0J, Kasirajan\u00a0V, Wood\u00a0MA, Kowalski\u00a0M, Han\u00a0FT, Ellenbogen\u00a0KA. Management of recurrfent atrial arrhythmias after minimally invasive surgical pulmonary vein isolation and ganglionic plexi ablation for atrial fibrillation. Heart Rhythm. 2010;7:445\u201351.","journal-title":"Heart Rhythm"},{"key":"1447_CR45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2011.12.055","volume":"60","author":"L Pison","year":"2012","unstructured":"Pison\u00a0L, La Meir\u00a0M, Van Opstal\u00a0J, Blaauw\u00a0Y, Maessen\u00a0J, Crijns\u00a0HJ. Hybrid thoracoscopic surgery and transvenous catheter ablation for atrial fibrillation. J\u00a0Am Coll Cardiol. 2012;60:54\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"1447_CR46","doi-asserted-by":"crossref","first-page":"e001754","DOI":"10.1161\/JAHA.114.001754","volume":"4","author":"A Bulava","year":"2015","unstructured":"Bulava\u00a0A, Mokracek\u00a0A, Hanis\u00a0J, Kurfirst\u00a0V, Eisenberger\u00a0M, Pesl\u00a0L. Sequential hybrid procedure for persistent atrial fibrillation. J\u00a0Am Heart Assoc. 2015;4:e1754.","journal-title":"J Am Heart Assoc"},{"key":"1447_CR47","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/CIRCEP.111.961862","volume":"4","author":"SPJ Krul","year":"2011","unstructured":"Krul\u00a0SPJ, Driessen\u00a0AHG, Van Boven\u00a0WJ, et al. Thoracoscopic video-assisted pulmonary vein antrum isolation, ganglionated plexus ablation, and periprocedural confirmation of ablation lesions. First results of a\u00a0hybrid surgical-electrophysiological approach for atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4:262\u201370.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1447_CR48","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.hrthm.2017.08.024","volume":"14","author":"SK Haldar","year":"2017","unstructured":"Haldar\u00a0SK, Jones\u00a0DG, Bahrami\u00a0T, et al. Catheter ablation versus electrophysiologically guided thoracoscopic ablation in long standing persistent atrial fibrillation (CASA-AF). Heart Rhythm. 2017;14:1596\u2013603.","journal-title":"Heart Rhythm"},{"key":"1447_CR49","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jacep.2015.09.013","volume":"1","author":"SPJ Krul","year":"2015","unstructured":"Krul\u00a0SPJ, Berger\u00a0WR, Veldkamp\u00a0MW, et\u00a0al. Treatment of atrial and ventricular arrhythmias through autonomic modulation. JACC Clin Electrophysiol. 2015;1:496\u2013508.","journal-title":"JACC Clin Electrophysiol"},{"key":"1447_CR50","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.jacc.2013.06.053","volume":"62","author":"DG Katritsis","year":"2013","unstructured":"Katritsis\u00a0DG, Pokushalov\u00a0E, Romanov\u00a0A, et\u00a0al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a\u00a0randomized clinical trial. J\u00a0Am Coll Cardiol. 2013;62:2318\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"1447_CR51","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jacc.2016.06.036","volume":"68","author":"AHG Driessen","year":"2016","unstructured":"Driessen\u00a0AHG, Berger\u00a0WR, Krul\u00a0SPJ, et\u00a0al. Ganglion plexus ablation in advanced atrial fibrillation. The AFACT study. J\u00a0Am Coll Cardiol. 2016;68:1155\u201365.","journal-title":"J Am Coll Cardiol"},{"key":"1447_CR52","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2459\/JCM.0000000000000868","volume":"20","author":"NWE van den Berg","year":"2019","unstructured":"van den Berg\u00a0NWE, Neefs\u00a0J, Berger\u00a0WR, et\u00a0al. PREventive left atrial appenDage resection for the predICtion of fuTure atrial fibrillation: design of the PREDICT AF study. J\u00a0Cardiovasc Med. 2019;20:752\u201361.","journal-title":"J Cardiovasc Med"},{"key":"1447_CR53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche\u00a0NF, Brachmann\u00a0J, Andresen\u00a0D, et\u00a0al. Catheter ablation for atrial fibrillation with heart failure. N\u00a0Engl J Med. 2018;378:417\u201327.","journal-title":"N Engl J Med"},{"key":"1447_CR54","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","volume":"321","author":"DL Packer","year":"2019","unstructured":"Packer\u00a0DL, Mark\u00a0DB, Robb\u00a0RA, et\u00a0al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321:1261\u201374.","journal-title":"JAMA"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01447-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-020-01447-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01447-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T14:44:26Z","timestamp":1667745866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-020-01447-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":54,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1447"],"URL":"https:\/\/doi.org\/10.1007\/s12471-020-01447-5","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"11 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.\u00a0Boersma declares consulting fees to Department of Cardiology, St.Antonius Hospital Nieuwegein. M.\u00a0Rienstra and J.R.\u00a0de\u00a0Groot declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}